Assignee
CV THERAPEUTICS INC
US100 patents
Top patents by PatentIndex Score
US6403567B1Jun 11, 2002
N-pyrazole A2A adenosine receptor agonists
CV THERAPEUTICS INC112 citations99
US6977300B2Dec 20, 2005
A2B adenosine receptor antagonists
CV THERAPEUTICS INC69 citations98
US6825349B2Nov 30, 2004
A2B adenosine receptor antagonists
CV THERAPEUTICS INC95 citations98
US6605597B1Aug 12, 2003
Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
CV THERAPEUTICS INC97 citations98
US5866702AFeb 2, 1999
Purine inhibitors of cyclin dependent kinase 2
CV THERAPEUTICS INC142 citations97
US7553823B2Jun 30, 2009
C-pyrazole A2A receptor agonists
CV THERAPEUTICS INC48 citations96
US7183264B2Feb 27, 2007
N-pyrazole A2A receptor agonists
CV THERAPEUTICS INC48 citations96
US7160592B2Jan 9, 2007
Polymer coating for medical devices
CV THERAPEUTICS INC211 citations96
US7144872B2Dec 5, 2006
N-pyrazole A2A receptor agonists
CV THERAPEUTICS INC50 citations96
US7109180B2Sep 19, 2006
C-pyrazole A2A receptor agonists
CV THERAPEUTICS INC43 citations96
US6852724B2Feb 8, 2005
Sustained release ranolazine formulations
CV THERAPEUTICS INC37 citations96
US6770634B1Aug 3, 2004
C-pyrazole a2a receptor agonists
CV THERAPEUTICS INC46 citations96
US6642210B1Nov 4, 2003
2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
CV THERAPEUTICS INC61 citations96
US6573264B1Jun 3, 2003
Heteroaryl alkyl piperazine derivatives
CV THERAPEUTICS INC60 citations96
US6552023B2Apr 22, 2003
Aralkyl substituted piperazine compounds
CV THERAPEUTICS INC64 citations96
US6479496B1Nov 12, 2002
Methods for treating angina with ranolazine
CV THERAPEUTICS INC55 citations96
US6294522B1Sep 25, 2001
N6 heterocyclic 8-modified adenosine derivatives
CV THERAPEUTICS INC122 citations96
US6214807B1Apr 10, 2001
C-pyrazole 2A A receptor agonists
CV THERAPEUTICS INC74 citations96
US6075150AJun 13, 2000
α-ketoamide inhibitors of 20S proteasome
CV THERAPEUTICS INC96 citations96
US5789416AAug 4, 1998
N6 mono heterocyclic substituted adenosine derivatives
CV THERAPEUTICS INC107 citations96
US6677336B2Jan 13, 2004
Substituted piperazine compounds
CV THERAPEUTICS INC59 citations95
US6620814B2Sep 16, 2003
Sustained release ranolazine formulations
CV THERAPEUTICS INC35 citations95
US6617328B2Sep 9, 2003
Sustained release ranolazine formulations
CV THERAPEUTICS INC32 citations95
US6548548B2Apr 15, 2003
ABCA-1 elevating compounds
CV THERAPEUTICS INC61 citations95
US6525057B2Feb 25, 2003
Sustained release ranolazine formulations
CV THERAPEUTICS INC44 citations95
US6503911B2Jan 7, 2003
Sustained release ranolazine formulations
CV THERAPEUTICS INC36 citations95
US6369062B1Apr 9, 2002
Sustained release ranolazine formulations
CV THERAPEUTICS INC37 citations95
US6781000B1Aug 24, 2004
Alpha-ketoamide inhibitors of 20S proteasome
CV THERAPEUTICS INC50 citations94
US6677342B2Jan 13, 2004
Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
CV THERAPEUTICS INC72 citations94
US6303607B1Oct 16, 2001
Method for administering a sustained release ranolanolazine formulation
CV THERAPEUTICS INC53 citations94
US6562826B1May 13, 2003
Sustained release ranolazine formulations
CV THERAPEUTICS INC31 citations93
US7317017B2Jan 8, 2008
A2B adenosine receptor antagonists
CV THERAPEUTICS INC22 citations92
US7304070B2Dec 4, 2007
A2B adenosine receptor antagonists
CV THERAPEUTICS INC23 citations92
US7125993B2Oct 24, 2006
A2B adenosine receptor antagonists
CV THERAPEUTICS INC37 citations92
US6946449B2Sep 20, 2005
Partial and full agonists of A1 adenosine receptors
CV THERAPEUTICS INC26 citations92
US6451798B2Sep 17, 2002
Substituted alkyl piperazine derivatives
CV THERAPEUTICS INC26 citations92
US6440948B1Aug 27, 2002
Thiophene A2A receptor agonists
CV THERAPEUTICS INC19 citations92
US6180615B1Jan 30, 2001
Propargyl phenyl ether A2A receptor agonists
CV THERAPEUTICS INC26 citations92
US7582617B2Sep 1, 2009
Myocardial perfusion imaging method
CV THERAPEUTICS INC27 citations91
US6794390B2Sep 21, 2004
Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha
CV THERAPEUTICS INC43 citations91
US6900219B2May 31, 2005
ABCA-1 elevating compounds
CV THERAPEUTICS INC23 citations90
US6599283B1Jul 29, 2003
Method of preventing reperfusion injury
CV THERAPEUTICS INC53 citations90
US7364768B2Apr 29, 2008
Polymer coating for medical devices
CV THERAPEUTICS INC14 citations89
US6528511B2Mar 4, 2003
Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
CV THERAPEUTICS INC22 citations89
US7238700B2Jul 3, 2007
A2B adenosine receptor antagonists
CV THERAPEUTICS INC11 citations84
US7105665B2Sep 12, 2006
A2B adenosine receptor antagonists
CV THERAPEUTICS INC12 citations84
US6818647B2Nov 16, 2004
Method and composition for restoring diuretic and renal function
CV THERAPEUTICS INC16 citations84
US7713946B2May 11, 2010
Partial and full agonists A1 adenosine receptors
CV THERAPEUTICS INC12 citations83
US6677343B2Jan 13, 2004
Substituted piperazine compounds
CV THERAPEUTICS INC15 citations83
US6576620B2Jun 10, 2003
Method of identifying partial adenosine A1 receptor agonists
CV THERAPEUTICS INC16 citations83
Showing the top 50 of 100 patents by PatentIndex Score.